Tomlinson said: "It's a postcode lottery and precise babelike connected the signifier and the clinician, but you tin deed barriers on the way." He added: "It's truly hard erstwhile you mightiness cognize idiosyncratic other who's going done precisely the aforesaid happening and has sailed done the process and mightiness not person gone into secondary care." He also noted: "There is nary consistency crossed the committee unfortunately."
Olver, who runs the menopause session at Aneurin Bevan's wellness committee, said: "we person decidedly seen a precise crisp summation successful testosterone referrals from superior attraction - for women wanting to entree it". She noted that each of the 7 wellness boards in Wales used a postulation airy strategy, with some areas coded red, meaning only specialists can prescribe the drug. She explained there are two amber options: one involves a GP requesting the enactment or statement from a hospital specialist that testosterone is due for a patient; the second requires the hospital specialist to initiate and show the medicine with a "shared attraction agreement", with GPs continuing to prescribe it.
Olver said: "One of the main reasons for this disparity is due to the fact that we don't person a licenced merchandise for pistillate connected the NHS." She pointed out that a female testosterone product has been available in other countries for many years and is obtainable from private clinics across the UK. She added that the product had secured a licence in the UK but still needs appraisal by NICE to determine cost‑effectiveness for NHS use, at which point discussions with the pharmaceutical industry about NHS costs would also be required.
Currently the female product, Androfeme, costs the NHS around £100, whereas the male product, Testogel, is £30. Olver cited studies showing that around 60% of women will find benefit in improving their libido. She stressed: "It's truly important to negociate expectations, due
Sincity Press Staff
1 day ago 2 min read
5 
English (US)·